From: Clinical application of noninvasive prenatal testing in the detection of fetal chromosomal diseases
No | Sample number | Age (years) | Gestational weeks | NIPT results | Karyotype results | CMA results and classification | Pregnancy outcome |
---|---|---|---|---|---|---|---|
1 | 19AH03422 | 30 | 16+3 | 2q12.1q12.3 duplicate 2.50Â Mb | 46,XN | 2q12.1q12 .3duplicate 2.51Â Mb, VOUS | Delivery, normal |
2 | 19AH05194 | 25 | 16+7 | 3p26.3 duplicate 2.50Â Mb | 46,XN | 3p26.3 duplicate 2.21Â Mb, Likely pathogenic | Delivery, normal |
3 | 20AH01147 | 35 | 18+2 | 2q13 lose 2.00Â Mb | 46,XN | 2q13 lose 2.12Â Mb, Likely pathogenic | Delivery, normal |
4 | 20AH00928 | 36 | 16+6 | 8q23.3-8q24 duplicate 29.00Â Mb | Refused | 8p23.3 lose 1.86Â Mb, 8p23.3p23.1 duplicate 4.92Â Mb, 8p23.1p12 lose 24.84Â Mb, 8p12q24.3 duplicate 113.39Â Mb, Pathogenic | Induced labor |
5 | 20AH02333 | 26 | 13+4 | 18q12.3 duplicate 2.00Â Mb | 46,XN | 18q12.3duplicate 1.03Â Mb, VOUS | Delivery, normal |
6 | 20AH01774 | 26 | 21+1 | 5p15.33-p14.3 duplicate 1.32Â Mb, 5q31.1-q35.3 duplicate 1.23Â Mb | 46,XN | 3p26.3duplicate 1.15Â Mb, VOUS | Delivery, normal |
7 | 20AH02846 | 25 | 17+6 | 5p15.33-p14.3 lose 19.50Â Mb | 46,XX, del(5) (p14) | 5p15.33-p14.3 lose 22.5Â Mb, Pathogenic | Induced labor |
8 | AB198R82670 | 37 | 17+5 | 6p12.3-6p12.1 lose 4.60Â Mb | 46,XN | 6p12.36p12.1duplicate 4.36Â Mb, VOUS | Delivery, normal |
9 | AB198R94013 | 26 | 18+1 | 18p11.32-18p11.21 lose 14.85Â Mb | 46,XN | 11q21q22.1 duplicate 1.89Â Mb, VOUS | Delivery, normal |
10 | AB19HG00152 | 32 | 19+3 | 22q11.21-22q11.21 duplicate 1.35Â Mb | 46,XN | 22q11-21 duplicate 2.35Â Mb, Pathogenic | Induced labor |
11 | AB198R04444 | 25 | 18+1 | 17p12 lose 2.50Â Mb | 46,XN | 17p12 lose 1.42Â Mb, Pathogenic | Delivery, normal |
12 | AB198R02692 | 34 | 21+2 | 3q26.33-3q27.1 duplicate 3.35Â Mb | 46,XN | 3q26.q27.1duplicate 3.29Â Mb, VOUS | Delivery, normal |
13 | AB198R02616 | 36 | 17+0 | 16p13.11-p12.3 duplicate 3.60Â Mb | 46,XN | 16p13.11p12.3 duplicate 2.67Â Mb, Likely pathogenic | Delivery, normal |
14 | AB19HG03892 | 28 | 14+6 | 12p11.21-12q12 duplicate 9.85Â Mb | 46,XN | 12p11.21p11.1-12q11q12 duplicate 2.49Â Mb, VOUS | Continued pregnancy |
15 | AB198R02189 | 38 | 20+5 | 1q21.1q21.2 duplicate 3.00Â Mb | 46,XN | 1q21.1q21.2duplicate 1.71Â Mb, Pathogenic | Induced labor |
16 | AB198R02191 | 31 | 17+5 | 17p13.1-17p12 duplicate 4.60Â Mb | 46,XN | 14q13.1 duplicate 550Â kb, VOUS | Delivery, normal |
17 | 20B0012795 | 20 | 18+4 | 8p22-p21.3 lose 5.21Â Mb | 46,XN | 8p22p21.3 lose 3.81Â Mb, VOUS | Delivery, normal |
18 | 20B0018624 | 30 | 17+2 | 13q33.1-q33.3 lose 5.68Â Mb | 46,XN | 13q33.1q33.3 lose 4.66Â Mb, Likely pathogenic | Delivery, normal |